Instil Bio (TIL) Competitors $23.91 +0.55 (+2.35%) (As of 09:30 AM ET) Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesOwnershipSEC FilingsShort InterestTrends TIL vs. ANAB, ORIC, TRML, DNTH, OCS, STOK, PHAT, IMNM, IGMS, and CDXCShould you be buying Instil Bio stock or one of its competitors? The main competitors of Instil Bio include AnaptysBio (ANAB), ORIC Pharmaceuticals (ORIC), Tourmaline Bio (TRML), Dianthus Therapeutics (DNTH), Oculis (OCS), Stoke Therapeutics (STOK), Phathom Pharmaceuticals (PHAT), Immunome (IMNM), IGM Biosciences (IGMS), and ChromaDex (CDXC). These companies are all part of the "pharmaceutical products" industry. Instil Bio vs. AnaptysBio ORIC Pharmaceuticals Tourmaline Bio Dianthus Therapeutics Oculis Stoke Therapeutics Phathom Pharmaceuticals Immunome IGM Biosciences ChromaDex AnaptysBio (NASDAQ:ANAB) and Instil Bio (NASDAQ:TIL) are both small-cap medical companies, but which is the better stock? We will contrast the two businesses based on the strength of their analyst recommendations, media sentiment, risk, community ranking, earnings, profitability, valuation, dividends and institutional ownership. Which has more risk & volatility, ANAB or TIL? AnaptysBio has a beta of -0.24, indicating that its stock price is 124% less volatile than the S&P 500. Comparatively, Instil Bio has a beta of 1.72, indicating that its stock price is 72% more volatile than the S&P 500. Which has better valuation and earnings, ANAB or TIL? Instil Bio has lower revenue, but higher earnings than AnaptysBio. AnaptysBio is trading at a lower price-to-earnings ratio than Instil Bio, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAnaptysBio$17.16M36.02-$163.62M-$6.08-3.34Instil BioN/AN/A-$156.09M-$11.56-2.07 Does the media prefer ANAB or TIL? In the previous week, AnaptysBio had 3 more articles in the media than Instil Bio. MarketBeat recorded 8 mentions for AnaptysBio and 5 mentions for Instil Bio. AnaptysBio's average media sentiment score of 0.08 beat Instil Bio's score of -0.28 indicating that AnaptysBio is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment AnaptysBio 1 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Instil Bio 1 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Neutral Do insiders and institutionals hold more shares of ANAB or TIL? 60.6% of Instil Bio shares are held by institutional investors. 33.7% of AnaptysBio shares are held by company insiders. Comparatively, 46.5% of Instil Bio shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock is poised for long-term growth. Does the MarketBeat Community prefer ANAB or TIL? AnaptysBio received 264 more outperform votes than Instil Bio when rated by MarketBeat users. Likewise, 66.12% of users gave AnaptysBio an outperform vote while only 50.25% of users gave Instil Bio an outperform vote. CompanyUnderperformOutperformAnaptysBioOutperform Votes36366.12% Underperform Votes18633.88% Instil BioOutperform Votes9950.25% Underperform Votes9849.75% Is ANAB or TIL more profitable? Instil Bio has a net margin of 0.00% compared to AnaptysBio's net margin of -289.75%. Instil Bio's return on equity of -37.44% beat AnaptysBio's return on equity.Company Net Margins Return on Equity Return on Assets AnaptysBio-289.75% -287.94% -37.25% Instil Bio N/A -37.44%-25.08% Do analysts recommend ANAB or TIL? AnaptysBio currently has a consensus target price of $54.64, suggesting a potential upside of 169.01%. Instil Bio has a consensus target price of $145.00, suggesting a potential upside of 506.44%. Given Instil Bio's higher possible upside, analysts plainly believe Instil Bio is more favorable than AnaptysBio.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score AnaptysBio 0 Sell rating(s) 2 Hold rating(s) 10 Buy rating(s) 0 Strong Buy rating(s) 2.83Instil Bio 0 Sell rating(s) 2 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 2.50 SummaryInstil Bio beats AnaptysBio on 9 of the 17 factors compared between the two stocks. Ad Crypto Swap Profits[625,000% Gain] – Are You Ready for the Next Altcoin Boom?All of our key indicators are flashing the same signal: an altcoin season is fast approaching. And if you know anything about crypto, you know that altcoin seasons are where some of the biggest gains happen.Register for the FREE Workshop Now & get $10 in Bitcoin Get Instil Bio News Delivered to You Automatically Sign up to receive the latest news and ratings for TIL and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart TIL vs. The Competition Export to ExcelMetricInstil BioBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$152.54M$2.93B$5.04B$8.81BDividend YieldN/A1.89%5.16%4.07%P/E Ratio-2.0246.01130.5317.82Price / SalesN/A360.251,183.8674.55Price / CashN/A160.0933.6132.53Price / Book0.673.734.684.68Net Income-$156.09M-$41.63M$119.23M$226.08M7 Day Performance-20.65%-4.73%-1.83%-1.04%1 Month Performance-33.07%-6.53%-3.61%1.04%1 Year Performance219.13%25.63%31.74%26.28% Instil Bio Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)TILInstil Bio2.8201 of 5 stars$23.91+2.4%$145.00+506.4%+208.2%$156.13MN/A-2.0749ANABAnaptysBio2.4863 of 5 stars$20.31+1.7%$54.64+169.0%+40.0%$618.03M$17.16M-3.34100ORICORIC Pharmaceuticals4.1915 of 5 stars$8.72-0.2%$18.29+109.7%+22.4%$615.37MN/A-4.8680Analyst RevisionTRMLTourmaline Bio1.7009 of 5 stars$23.80-0.8%$65.00+173.1%+36.0%$610.23MN/A0.0044DNTHDianthus Therapeutics1.506 of 5 stars$20.57-1.0%$46.43+125.7%+78.7%$608.87M$2.83M0.0080OCSOculis2.6784 of 5 stars$14.91-0.7%$29.20+95.8%+55.3%$603.86M$980,000.000.002STOKStoke Therapeutics3.8497 of 5 stars$11.34+0.3%$20.83+83.7%+171.2%$600.68M$8.78M0.00100PHATPhathom Pharmaceuticals2.3252 of 5 stars$8.61-1.4%$22.50+161.3%+17.8%$588.75M$680,000.00-1.53110IMNMImmunome1.533 of 5 stars$9.33-0.6%$28.83+209.0%+19.8%$582.38M$14.02M0.0040Analyst RevisionIGMSIGM Biosciences4.7018 of 5 stars$9.76-0.1%$16.13+65.2%+63.3%$580.33M$2.13M0.00190CDXCChromaDex3.9237 of 5 stars$7.50-0.3%$8.00+6.7%+417.2%$572.85M$83.57M750.75106Analyst Downgrade Related Companies and Tools Related Companies ANAB Competitors ORIC Competitors TRML Competitors DNTH Competitors OCS Competitors STOK Competitors PHAT Competitors IMNM Competitors IGMS Competitors CDXC Competitors Top 10 Stock Comparisons Bank Stocks Artificial Intelligence Stocks Toy Stocks Growth Stocks Airline Stocks Chinese Stocks EV Charging Stocks Defense Stocks Lithium Stocks Pharmaceutical Stocks This page (NASDAQ:TIL) was last updated on 11/21/2024 by MarketBeat.com Staff From Our PartnersThe Crypto That’s Making Wall Street SweatThe Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...Crypto 101 Media | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredCrypto’s next big bull run?Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...Weiss Ratings | Sponsored“This Changes Everything” - Trump Hands Millions Massive IRS GiftNow it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...Colonial Metals | SponsoredTim Sykes’ Urgent Trade Alert: “Make this move now”WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...Timothy Sykes | SponsoredUnveiled: NVIDIA’s "Secret Royalty" ProgramDid you know that there's an investment that will give you the opportunity to collect "royalties" every time N...Behind the Markets | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Instil Bio, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Instil Bio With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free TIL Stock Alerts